UCB
UCB's Patient Evidence Graduate Development Program is a two-year rotational opportunity for recent graduates to launch their careers in a global biopharmaceutical company. Participants will rotate through key teams like Regulatory Stakeholders and Patient Communities to understand patient needs and generate scientific evidence. This role emphasizes gaining exposure to digital transformation, clinical operations, and regulatory processes while developing technical and interpersonal skills.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
76% above the average for this role
Pfizer Grange Castle Graduate Programme 2026
Pfizer
BioMarin 2027 Graduate Programme - Science
biomarin
Manufacturing Leadership Development Program
Merck & Co., Inc.
2027 Graduate - Digital (Digital & Data) Analyst - Bristol
PA Consulting
Manufacturing Leadership Development Program
Merck & Co., Inc.
Technical Graduate Programme 2026
NKT